Prj Genesis Neurogen Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -49.45%
- Profit Growth -121.65%
- Ebitda -51.14%
- Net Worth -1.93%
- Total Assets -33.06%
About Prj Genesis Neurogen
Prj Genesis Neurogen Private Limited (PGNPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2017 (Seven years and nine months 20 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Piyush Jain and Radha Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110DL2017PTC316650
-
Company No.
316650
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Prj Genesis Neurogen?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Jain
|
Director | 25-Apr-2017 | Current |
|
Radha Jain
|
Director | 25-Apr-2017 | Current |
Financial Performance of Prj Genesis Neurogen.
Prj Genesis Neurogen Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 49.45% decrease. The company also saw a substantial fall in profitability, with a 121.65% decrease in profit. The company's net worth dipped by a decrease of 1.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prj Genesis Neurogen?
Unlock access to Prj Genesis Neurogen's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Global Intensive Care LlpPiyush Jain and Radha Jain are mutual person
-
Prmc Genesis Neurogen Private Limited
Piyush Jain and Radha Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prj Genesis Neurogen?
Unlock and access historical data on people associated with Prj Genesis Neurogen, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prj Genesis Neurogen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prj Genesis Neurogen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.